TRB Wealth Management’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.7K Hold
11,326
– – ﹤0.01% 283
2026
Q2
$15.9K Hold
11,326
– – ﹤0.01% 295
2026
Q1
$19.1K Hold
11,326
– – ﹤0.01% 285

Other funds holding CHRS

TRB Wealth Management's CHRS Position: Q3 2026 in Review

TRB Wealth Management held its Coherus Oncology (CHRS) position steady in Q3 2026 at 11,326 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #283.

TRB Wealth Management first reported a position in CHRS in Q1 2026 and has held it in 3 quarters since. The position peaked at $19.1K in Q1 2026. 136 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

  • TRB Wealth Management held 11,326 shares of Coherus Oncology worth $13.7K as of Q3 2026.
  • TRB Wealth Management left its Coherus Oncology share count unchanged in Q3 2026.
  • Coherus Oncology made up ﹤0.01% of TRB Wealth Management's portfolio in Q3 2026, its #283 holding.
  • TRB Wealth Management first reported a position in Coherus Oncology in Q1 2026 and has held it in 3 quarters since.
  • TRB Wealth Management's Coherus Oncology position peaked at $19.1K in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on TRB Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.